Cell Harvesting Systems Market: Automation, Closed Systems, and Core Technologies Reshaping Cell Recovery

The cell harvesting systems market focuses on technologies and devices used to collect, isolate, and prepare cells for applications in research, therapeutics, and diagnostics. These systems are essential in regenerative medicine, cell-based therapies, and biopharmaceutical production. For manufacturers and buyers, the technology choices behind these systems increasingly determine efficiency, sterility, and scalability.

Market Overview

According to Polaris Market Research, the global cell harvesting systems market was valued at USD 6.02 billion in 2024. It is projected to grow from USD 6.87 billion in 2025 to USD 22.98 billion by 2034, at a CAGR of 14.3% from 2025 to 2034. North America was the largest regional market in 2024.

The report names the rising prevalence of chronic diseases, increasing demand for personalized medicine, and advancements in biotechnology among the key growth factors. It also points to growing investments in stem cell research and expanding applications in immunotherapy.

Automated Cell Harvesting Improves Efficiency and Reproducibility

The increasing adoption of automated systems is transforming the market, driven by their ability to enhance efficiency and reduce human error in cell recovery processes. Automated cell harvesting is particularly beneficial in large-scale biopharmaceutical production, where precision and reproducibility are critical.

Automated systems also support scalability, enabling seamless transitions from research to clinical and commercial manufacturing. The report cites a 2022 Nature Biotechnology study indicating that automation in bioprocessing has improved cell yield by up to 30% compared with manual methods, and it links this trend to the broader push to integrate automation and robotics in life sciences.

Closed-System Harvesting and Contamination Control

The shift toward closed-system harvesting is gaining momentum because of its ability to prevent contamination and maintain sterility throughout cell collection. Closed systems are essential for meeting stringent regulatory requirements and ensuring product safety, particularly in clinical and commercial production environments.

The report references a 2021 study in the Journal of Bioprocessing and Biotechnology noting that closed systems reduce contamination risks by over 80% compared with open systems. It expects the shift to continue as industry standards increasingly favor aseptic processes, which supports demand for closed-system harvesting in regenerative medicine and stem cell therapies.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :

https://www.polarismarketresearch.com/industry-analysis/cell-harvesting-systems-market 

CAR-T Cell Therapy and the Immunotherapy Opportunity

The growing prominence of immunotherapy, particularly in oncology, is driving the development of advanced harvesting systems. Techniques such as CAR-T cell therapy and other cell-based immunotherapies require efficient and sterile cell collection methods to ensure therapeutic efficacy.

The report notes that, according to the National Cancer Institute, over 1,000 clinical trials involving CAR-T therapies were ongoing globally in 2023, highlighting demand for supporting technologies. Manufacturers are increasingly developing systems compatible with personalized treatments. In October 2024, Miltenyi Biotec introduced a high-throughput platform for cell enrichment to support large-scale immunotherapy production, and in January 2025 Terumo BCT partnered with FUJIFILM Irvine Scientific to integrate the Quantum Flex platform with PRIME-XV media for faster, more efficient T-cell expansion. These examples show how CAR-T cell therapy workflows are shaping product development.

Blastomere Extraction and Altered Nuclear Transfer

By technology, the market is segmented into blastomere extraction and altered nuclear transfer. Blastomere extraction held the largest market share in 2024 because of its extensive application in preimplantation genetic testing (PGT) and embryonic stem cell research. It is widely used in assisted reproductive technologies, supported by rising awareness of genetic testing and the rising prevalence of infertility.

Altered nuclear transfer is anticipated to register the highest CAGR from 2025 to 2034, propelled by its emerging role in regenerative medicine and therapeutic cloning. The report notes that it offers potential for generating patient-specific pluripotent stem cells without the ethical concerns associated with embryonic stem cell research, and that investments in regenerative medicine research and advances in nuclear reprogramming are accelerating growth.

Conclusion

The cell harvesting systems market is poised for growth due to increasing demand for advanced cell-based research and biopharmaceutical production. The expansion of regenerative medicine, cell therapy, and tissue engineering is creating new opportunities for specialized harvesting technologies. Pharmaceutical and biotechnology companies are investing in systems that improve cell recovery, viability, and processing efficiency. Automation and closed-system technologies are also helping reduce contamination risks and support consistent results. Continued progress in biomedical research is expected to strengthen demand for advanced cell harvesting solutions. Overall, the market outlook remains promising as cell-based therapies and biomanufacturing continue to advance.

More Trending Latest Reports By Polaris Market Research:

Security Inks Market

IT Services Market

Edible Oils & Fat Market

Cell & Gene Therapy Bioanalytical Testing Services Market

IT Services Market

Telehealth Market

Restaurant Point-Of-Sale (Pos) Terminals Market

Major Innovations in the Electric Scooter to Positively Influence the Global Industry

Opioid Market